6,045 filings
Page 11 of 100
6-K
2u9tqf0zy1ku8r
28 Mar 23
Positive Phase III Ruby Results for Jemperli
8:00am
6-K
looe 8f5xeuto
27 Mar 23
Publication of 2023 Agm Notice
8:51am
6-K
x9sl62rkl5e4eeqly4
24 Mar 23
Statement: Zantac (Ranitidine) Litigation
8:29am
6-K
w9wawzo dwc5yp8
21 Mar 23
Director/pdmr Shareholding
11:36am
6-K
r8y jti2x1sf2x
20 Mar 23
Director/pdmr Shareholding
11:41am
EFFECT
builw6l1sfnkpc8
16 Mar 23
Notice of effectiveness
12:15am
6-K
a2bzb9nm
14 Mar 23
Positive Phase III Results for Menabcwy Vaccine
7:11am
6-K
pn7onjgxghzkewv4exi
14 Mar 23
Nucala Nda Accepted for Review In China
7:04am
6-K
dmdyjmarnu62r5 aoc
13 Mar 23
Director/pdmr Shareholding
11:39am
POS AM
l4wd860vjhr5og6u
10 Mar 23
Prospectus update (post-effective amendment)
12:20pm
6-K
xbkyrucyue05qerl5w
10 Mar 23
GSK Annual Report 2022 on Form 20-F
12:16pm
IRAN
0mh8qt
10 Mar 23
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
11:22am
6-K
my12ag5h 65cpta
10 Mar 23
GSK Publishes Annual Report 2022
6:53am
6-K
yj9ty8
2 Mar 23
Fda Ad Com Votes to Support GSK RSV Oa Vaccine
6:33am
6-K
tlxi 848m75v
1 Mar 23
Total Voting Rights
12:05pm
6-K
rel x9izsr5haurro
27 Feb 23
Director/pdmr Shareholding
11:12am
6-K
hkhx6kfe3vrc
23 Feb 23
Director/pdmr Shareholding
10:36am
6-K
2x0rbzrbdpepi
23 Feb 23
VIIV Healthcare Announces Cabenuva Positive Data
6:22am
6-K
fbde2
22 Feb 23
Director/pdmr Shareholding
12:37pm